Quinolones in 2005: an update

Quinolones in 2005: an update.

Quinolones are one of the largest classes of antimicrobial agents used worldwide. This review considers the quinolones that are available currently and used widely in Europe (norfoxacin, ciprofloxacin, ofloxacin, levofloxacin and moxifloxacin) within their historical perspective, while trying to position them in the context of recent and possible future advances based on an understanding of: (1...

Update in transplantation 2005.

The current status of the field over the past several years was summarized in the 2005 Official Report of the Registry of the International Society for Heart and Lung Transplantation (ISHLT) (1). The overall level of activity reported in 2003 was close to that of 2002, including 931 bilateraland 772 singlelung transplantations, and 74 heart–lung transplantations. The number of bilateral procedu...

Guidelines ICD implantation 2005 – an update

Magnet Recognition Program 2005: an update.

The Magnet Recognition Program has been revised to simplify instructions, eliminate redundancy, and reduce the documentation burden for applicants. One of the major changes is that required documentation is now categorized by the 14 Forces of Magnetism to match the Scope and Standards for Nurse Administrators (American Nurses Association [ANA], 2004) through the use of a crosswalk matrix. Howev...

Update in pulmonary hypertension 2005.

This article summarizes and puts into perspective the most important advances made in 2005 in the field of pulmonary vascular disease. The focuswill be entirely on pathogenetic and therapeutic aspects of pulmonary hypertension, although important articles have also been published in other areas of pulmonary vascular disease, including pulmonary embolism (1, 2) and high-altitude pulmonary edema ...